Esplora le ultime tendenze nel biopharma mentre discutiamo storie significative, sfide e innovazioni, dalle approvazioni della FDA ai cambiamenti del settore e alla regolamentazione dell'IA.
Sarepta Gets Reprieve, RFK Jr.’s New Changes, Roche’s Alzheimer’s Comeback and Q2 Earnings
19 mins • Jul 30, 2025
Charts
- 168NEW
- 20Increased by 0
- 29Decreased by 3
- 96Increased by 0
- 36Decreased by 3
Episodi recenti

Jul 30, 2025
Sarepta Gets Reprieve, RFK Jr.’s New Changes, Roche’s Alzheimer’s Comeback and Q2 Earnings
19 mins

Jul 23, 2025
Sarepta’s Wild Week, CDER’s New Leader, FDA Rejections, Manufacturing Billions
24 mins

Jul 22, 2025
Why Countries Are Racing to Build mRNA Factories While America Hesitates on Next-Gen Vaccines
15 mins

Jul 17, 2025
AI Is Taking Over Drug Safety Monitoring–But There's One Thing It Can't Replace
13 mins

Jul 16, 2025
FDA Layoffs, 200 Rejection Letters, User Fees and Priority Vouchers, Bad Week for Rare Disease
26 mins

Lingua
Inglese
Paese
Stati Uniti
Feed Host
Sito web
Feed
Richiedi un aggiornamento
Gli aggiornamenti potrebbero richiedere alcuni minuti.